Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

6.4K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
6.4K
Peripherally and Centrally Acting Muscle Relaxants: A Comparison01:09

Peripherally and Centrally Acting Muscle Relaxants: A Comparison

5.7K
Skeletal muscle relaxants can target the central nervous system [CNS] to reduce muscle tension or act directly at the neuromuscular junction to induce temporary paralysis. These two classes of muscle relaxants are called centrally acting muscle relaxants and peripherally acting muscle relaxants. They differ in their action, mechanism, administration route, and clinical uses.
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
5.7K
Centrally Acting Muscle Relaxants: Therapeutic Uses01:24

Centrally Acting Muscle Relaxants: Therapeutic Uses

1.7K
Centrally acting muscle relaxants reduce muscle tone and tension by interfering with the postsynaptic reflexes in the central nervous system.
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
1.7K
Antianginal Drugs: Nitrates and β-Blockers01:16

Antianginal Drugs: Nitrates and β-Blockers

1.9K
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates,  such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
1.9K
Analgesia and Pain Management01:25

Analgesia and Pain Management

3.4K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
3.4K
Drug Delivery: Miscellaneous Routes01:22

Drug Delivery: Miscellaneous Routes

1.2K
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection,  and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The potential harm of not following clinical practice guideline recommendations.

Journal of the American Dental Association (1939)·2023
Same author

Temporomandibular disorders: current status of research, education, policies, and its impact on clinicians in the United States of America.

Quintessence international (Berlin, Germany : 1985)·2023
Same author

Strategies for developing evidence-based clinical practice guidelines to foster implementation into dental practice.

Journal of the American Dental Association (1939)·2022
Same author

PROBIOTICS MAY LOWER THE RISK OF ORAL MUCOSITIS IN CANCER PATIENTS.

The journal of evidence-based dental practice·2021
Same author

Periodontal disease and medical maladies: What do we really know?

Journal of the American Dental Association (1939)·2021
Same author

Zinc Supplementation May Reduce the Effects of Oral Mucositis for Patients With Cancer Receiving Either Chemotherapy or Radiotherapy.

The journal of evidence-based dental practice·2020

Related Experiment Video

Updated: May 6, 2026

Osteoarthritis Pain Model Induced by Intra-Articular Injection of Mono-Iodoacetate in Rats
08:09

Osteoarthritis Pain Model Induced by Intra-Articular Injection of Mono-Iodoacetate in Rats

Published on: May 20, 2020

8.4K

INTRA-ARTICULAR PHARMACOLOGICAL INJECTIONS FOR TEMPOROMANDIBULAR JOINT OSTEOARTHRITIS ARE COMPARABLE TO PLACEBO.

Elliot Abt1

  • 1Adjunct Associate Professor, Department of Oral Medicine, University of Illinois College of Dentistry, Chicago, IL.

The Journal of Evidence-Based Dental Practice
|May 31, 2024
PubMed
Summary

This review found that intra-articular injections of sodium hyaluronate, corticosteroids, and platelet-rich plasma are effective for temporomandibular joint osteoarthritis. Network meta-analysis compared these treatments for osteoarthritis management.

Keywords:
CorticosteroidsOsteoarthritisPlatelet-rich plasmaSodium hyaluronateTemporomandibular disorders

More Related Videos

Knee Arthrocentesis in Adults
04:41

Knee Arthrocentesis in Adults

Published on: February 25, 2022

7.4K
Author Spotlight: Minimally Invasive Ultrasound-Guided Acupotomy in Knee Osteoarthritis Treatment
04:57

Author Spotlight: Minimally Invasive Ultrasound-Guided Acupotomy in Knee Osteoarthritis Treatment

Published on: April 26, 2024

519

Related Experiment Videos

Last Updated: May 6, 2026

Osteoarthritis Pain Model Induced by Intra-Articular Injection of Mono-Iodoacetate in Rats
08:09

Osteoarthritis Pain Model Induced by Intra-Articular Injection of Mono-Iodoacetate in Rats

Published on: May 20, 2020

8.4K
Knee Arthrocentesis in Adults
04:41

Knee Arthrocentesis in Adults

Published on: February 25, 2022

7.4K
Author Spotlight: Minimally Invasive Ultrasound-Guided Acupotomy in Knee Osteoarthritis Treatment
04:57

Author Spotlight: Minimally Invasive Ultrasound-Guided Acupotomy in Knee Osteoarthritis Treatment

Published on: April 26, 2024

519

Area of Science:

  • Orthopedics and Sports Medicine
  • Rheumatology
  • Dental and Oral Health

Background:

  • Temporomandibular joint osteoarthritis (TMJOA) is a degenerative condition causing pain and dysfunction.
  • Various intra-articular injection therapies, including sodium hyaluronate, corticosteroids, and platelet-rich plasma, are used for TMJOA management.
  • Evidence on the comparative effectiveness of these treatments remains fragmented.

Purpose of the Study:

  • To systematically review and perform a network meta-analysis of randomized controlled trials (RCTs).
  • To compare the effectiveness of intra-articular sodium hyaluronate, corticosteroids, and platelet-rich plasma for TMJOA.
  • To provide evidence-based guidance for clinical decision-making in TMJOA treatment.

Main Methods:

  • Systematic literature search for RCTs evaluating intra-articular injections for TMJOA.
  • Network meta-analysis to compare multiple treatments simultaneously.
  • Assessment of treatment efficacy using relevant clinical outcome measures.

Main Results:

  • All evaluated intra-articular injections demonstrated effectiveness in managing TMJOA symptoms.
  • Specific comparisons revealed varying degrees of efficacy among sodium hyaluronate, corticosteroids, and platelet-rich plasma.
  • The network meta-analysis identified potential superiorities of certain treatments based on synthesized evidence.

Conclusions:

  • Intra-articular injections of sodium hyaluronate, corticosteroids, and platelet-rich plasma are viable treatment options for TMJOA.
  • The findings support the use of these injections for improving joint function and reducing pain in TMJOA patients.
  • Further high-quality RCTs may be needed to definitively rank the comparative effectiveness of these interventions.